APP Pharmaceuticals Launches Rocuronium Bromide Injection (Business Wire via Yahoo! Finance) PDF Print

SCHAUMBURG, Ill.----APP Pharmaceuticals, Inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched Rocuronium Bromide Injection, the generic equivalent of Organon’s Zemuron®.

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.